Mobia Medical (MOBI)
Implanted neurostimulation therapy paired with rehabilitation for chronic stroke recovery.
$9.70
After hours+0.13 (+1.31%)
At close$9.58(−1.39%)
In millions of USD, except per-share figures
| In millions | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|
| Revenue | 12 | 14 |
| Cost of revenue | 2 | 2 |
| Gross profit | 10 | 11 |
| 27 | 29 | |
| Research & development | 2 | 2 |
| Selling, general & administrative | 25 | 27 |
| Operating income | −17 | −18 |
| −1 | −3 | |
| Interest expense | 0 | 0 |
| Other non-operating income | 0 | 0 |
| Income before tax | −18 | −21 |
| Income tax expense | 0 | 0 |
| Net income from continuing operations | −18 | −21 |
| Net income | −18 | −21 |
| EPS, basic | −$0.54 | −$1.10 |
| EPS, diluted | −$0.54 | −$1.10 |
| Weighted average shares, basic | 33 | 19 |
| Weighted average shares, diluted | 33 | 19 |
| EBITDA | −17 | −18 |
| Depreciation & amortization | 0 | 0 |
| EBIT | −17 | −18 |